Overview
H1 is an AI-powered platform that helps healthcare companies connect with the right doctors [2]. Founded in 2020, the company went through Y Combinator's Winter 2020 batch [4]. Based in New York City [8], H1 operates a global platform of healthcare professionals and healthcare organizations [6], connecting stakeholders across the healthcare ecosystem [7]. As of the Y Combinator directory listing, the company has a team size of 500 [5]. In 2026, H1 announced a partnership with Novo Nordisk to apply AI to clinical trial design, site selection and enrollment, and acquired rights to further advance Novo Nordisk's StudyHub clinical development platform [1].
H1 helps connect the healthcare ecosystem by providing a global platform of every healthcare professional and healthcare organization. [5]
Y Combinator's directory lists the company location as New York City, NY, USA; New York, NY, USA. [8]
Growth & traction
Y Combinator lists a team size of 500. [4]
Funding & milestones
1 events found for H1 · 2026
VentureVenture / equityDetails$40M
Reported amount $40,000,000
Source not attached to this recordDeal recordInvestorsCHCVS Health Ventures
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Leadership & org chart
Recent developments
- H1 partners with Novo Nordisk on AI-driven clinical development. H1 announced a partnership with Novo Nordisk to apply AI to clinical trial design, site selection and enrollment, and acquired rights to further advance Novo Nordisk's StudyHub clinical development platform.[1]Aug 4, 2026
Focus
- H1 describes itself as "H1 is the connecting force for global HCP, clinical, scientific and research information.".[9]
Backers
Something wrong or missing? Send an update. Fixed within 24 hours.